A single reversed-phase UPLC method for quantification of levofloxacin in aqueous humour and pharmaceutical dosage forms

Journal of Chromatographic Science

Volumn 48, Issue 6, 2010, Pages 484-490

  Gupta, Himanshu ^a   Aqil, M ^a   Khar, R K ^a   Ali, Asgar ^a   Chander, Prakash ^b  

^a HAMDARD UNIVERSITY   (India)

^b CSC India Pvt Ltd   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77955497808     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/48.6.484     Document Type: Article

References (27)

1. W. G. Mark. Comparative antimicrobial activity of levofloxacin and ciprofloxacin against Streptococcus pneumoniae. J. Antimicrob. Chemother. 52:503-506 (2003).
2. M. B. Frosco, J. L. Melton, F. P. Stewart, B. A. Kulwich, L. Licata, and J. F. Barrett. In vivo efficacies of levofloxacin and ciprofloxacin in acute Murine Hematogenous Pyelonephritis induced by Methicillin-susceptible and-resistant Staphylococcus aureus strains. Antimicrob. Agents Chemother. 40:2529-2534 (1996).
3. http://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid= 835
4. S. Ding. Recent developments in ophthalmic drug delivery. Pharm. Sci. Technol. Today 1:328-335 (1998).
5. J. M. Hill, O. Callaghan, R. J. Hobden, and J. A. Kaufman. Controlled collagen shields for ocular delivery. In: Mitra, A. K. (Ed.), Ophthalmic Drug Delivery Systems. Marcel Dekker, New York, 1993, pp 261-275.
6. C. L. Bourlais, L. Acar, H. Zia, P. A. Sado, T. Needham, and R. Leverge. Ophthalmic drug delivery systems-recent advance. Prog. Retinal Eye Res. 17:33-58 (1998).
7. H. R. N. Marona and E. E. S. Schapoval. Spectrophotometric determination of lev-ofloxacin in pharmaceutical formulations using bromothymol blue. J. Pharmaceut. Biomed. Anal. 26:501-504 (2001).
8. G. Altiokka, Z. Atkosar, and N. O. Can. The determination of levofloxacin by flow injection analysis using UV detection, potentiometry, and conductometry in pharmaceutical preparations. J. Pharmaceut. Biomed. Anal. 30:881-885 (2002).
9. D. J. Lyon, S. W. Cheung, C. Y. Chan, and A. F. Cheng. Rapid HPLC assay of clinafloxacin, fleroxacin, levofloxacin, levofloxacin and tosufloxacin. J. Antimicrob. Chemother. 34:446-448 (1994).
10. H. R. N. Marona, J. A. S. Zuanazzib, and E. E. S. Schapoval. Determination of levofloxacin and its degradation products by HPLC-PDA. J. Antimicrob. Chemother. 44:301-302 (1999).
11. H. R. N. Marona and E. E. S. Schapoval. A high-performance liquid chromato-graphic assay for levofloxacin. J. Pharmaceut. Biomed. Anal. 20:413-417 (1999).
12. S. Bottcher, H. V. Baum, T. T. Hoppe, C. Benz, and H. G. Sonntag. An HPLC assay and a microbiological to determine levofloxacin in soft tissue, bone, bile, and serum. J. Pharm. Biomed. Anal. 25:197-203 (2001).
13. F. K. Hurtado, D. R. Nogueira, F. Bortolini, L. M. Silva, E. Zimmermann, M. J. Souza, D. M. Janine, and C. M. B. Rolim. Determintion of levofloxacin in a pharmaceutical injectable formulation by using HPLC and UV spectrophotometric methods. J. Liq. Chromatogr. Relat. Technol. 30:1981-1989 (2007).
14. Du Ming Li, Zhe Feng Fan, Jin Li Qiao, and J. P. Wang. Determination of lev-ofloxacin in human urine by reversed-phase high-performance liquid chro-matography with nitrous acid and hydroiodic pre-column derivatization. Chin. Chem. Lett. 12:1007-1010 (2000).
15. K. Borner, E. Borner, and H. Lode. Determination of levofloxacin in serum and urine by high-performance liquid chromatography. J. Chromatogr. 579:285-289 (1992).
16. M. Kamberi, P. Kamberi, N. Hajime, N. Uemura, K. Nakamura, and S. Nakano. Determination of levofloxacin in plasma and urine by a simple and rapid liquid chromatographic method. Ther. Drug Monit. 21:411-415 (1999).
17. E. Nemutlu, S. Kir, O. Ozyuncu, and M. S. Beksac. Simultaneous separation and determination of seven quinolones using HPLC: Analysis of levofloxacin and moxifloxacin in plasma and amniotic fluid. Chromatographia 66:182 (2007).
18. M. I. R. M. Santoro, N. M. Kassab, A. K. Singh, and E. R. M. J. Kedor-Hackmam. Quantitative determination of gatifloxacin, levofloxacin, lomefloxacin and pefloxacin fluoroquinolonic antibiotics in pharmaceutical preparations by high performance liquid chromatography. J. Pharm. Biomed. Anal. 40:179-184 (2006).
19. J. P. Dae, B. P. Prasad, J. In-Jin, C. Song, J. M. Byung, E. K. Jung, K. Woomi, K. H. Sung, and R. Y. Young. An improved UPLC method for rapid analysis of lev-ofloxacin in human plasma. Chromatographia 68 (3-4): 187-192 (2008).
20. J. Bours. The protein distribution of bovine, human and rabbit aqueous humour and the difference in composition before and after disruption of the blood/aqueous humour barrier. Lens Eye Toxic Res. 7:491-503 (1990).
21. F. Schenkel, S. Rudaz, Y. Daali, M. K. Oestreicher, J. L. Veuthey, and P. Dayer. Development and validation of a new reversed-phase ion pairing liquid chro-matographic method with fluorescence detection for penciclovir analysis in plasma and aqueous humor. J. Chromatogr. B 826:1-7 (2005).
22. Text on Validation of analytical procedures, international conference on harmonization, September (1993).
23. Proceedings of the International Conference on Harmonization of Technical Requirements of Registration of Pharmaceuticals for Human Use (ICH Harmonized Tripartite Guidelines). Validation of Analytical Procedures: Methodology, ICH-Q2B, Geneva, (1996).
24. Q2 (R1) ICH guidelines, Validation of Analytical Procedures: Text and Methodology.
25. Proceedings of the International Conference on Harmonization of Technical Requirements of Registration of Pharmaceuticals for Human Use. Validation of Analytical Procedures, ICH-Q2A, Geneva, (1995)
26. Center for Drug Evaluation and Research, Reviewers Guidance, Validation of Chromatographic Methods, (1994).
27. H. Gupta, M. Aqil, R. K. Khar, A. Ali, A. Bhatnagar, G. Mittal, and S. Jain. Development and characterization of Tc-99m timolol maleate for evaluating efficacy of in situ ocular drug delivery system. AAPS Pharm. Sci. 10:540-546 (2009).